Mountain Valley MD Holdings Inc C.MVMD

Alternate Symbol(s): MVMDF

Metals & Mining Gold

Mountain Valley MD Holdings Inc. is a Canada-based biotech company, which is focused on advancing solutions to optimize human, animal, and plant health. The Company is focused on implementation, licensing and reselling of key technologies and formulations, such as Quicksome oral formulation and delivery technologies, Quicksol solubility formulation technology, and Agrarius, a novel agricultural plant signaling technology. Quicksome technology utilizes proprietary formulations and stabilizing molecules to encapsulate and formulate active ingredients into efficient product formats. Quicksol technology covers all solubilized macrocyclic lactones that could be applied in multiple viral applications that could impact human and animal health globally. Agrairus agricultural plant signaling technology is used as application to agricultural crops to naturally increase yields, reduce fertilizer usage, and enhance general resilience to pests and climate change.

CSE:MVMD - Post by User

Mountain Valley MD Holdings Inc > interesting short report. likely the reason for the fall

<< Previous

Bullboard Posts

Next >>

Comment by mingzhuon May 27, 2021 5:24pm

139 Views

Post# 33282964

RE:interesting short report. likely the reason for the fall

main points of the short

Mountain Valley has pivoted from one hype-filled sector to another – we believe its COVID effort will follow the same disastrous outcome as its failed cannabis endeavor
MVMD’s most tangible progress in cannabis was a series of investments that were written off completely resulting in cumulative losses of over $10m
MVMD’s lead scientist has peddled the same delivery technology for years across multiple product formats without success. MVMD claims the same technology can revolutionize medicine.
We find no evidence of MVMD’s lead scientist completing scientific training or a science-based degree (or any degree); no employees have pharmaceutical related experience
Management touts a TAM in the tens of billions, yet recently signed a tiny $250k licensing agreement with an obscure mushroom counterparty
The Chief Medical Officer of this mushroom company was forced to resign from taxpayer-funded clinic after an audit revealed he embezzled over $2m
MVMD recently halted its stock overnight to announce animal trials and a partner in Bangladesh. We reveal the partner is primarily a garment manufacturer located in same building as an elementary school (we have photos)
MVMD’s prolific stock promotion includes dozens of ads portrayed as unbiased interviews with known stock promoters
We interview two drug delivery experts – both extremely skeptical of MVMD and “struggle to see any value”
MVMD has only completed one pre-clinical study – in canines. Our experts are baffled Mountain Valley would hype the results, calling them vague and unremarkable
MVMD claims its products are “unprecedented”, yet it owns only two relevant patents (with the same title) of questionable value
MVMD’s flagship product candidate is a modified form of an unapproved drug with data criticized by most of the medical community including National Institutes of Health, Infectious Disease Society of America and Merck
Prior CFO founded a cannabis company whose stock declined 80% since IPO and just received a notice of default from debt holders
Three months ago, MVMD raised cash at 80% below current levels with warrants. The stock is up 6x since despite no meaningful news
MVMD quietly equitized $0.5m of debt at $0.07c/unit on the same day it announced an equity financing at $0.22/unit. Neither the debt nor the counterparty was disclosed